121 related articles for article (PubMed ID: 38916730)
1. Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.
Wang Z; Pan JP; Geng J; Lv S; Chen G; Fang N; Zhang Z; Li J; Xu X; Wang R; Zheng Q; Yan L; Chen G; Xiao F
Aging Dis; 2024 May; ():. PubMed ID: 38916730
[TBL] [Abstract][Full Text] [Related]
2. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
3. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
[TBL] [Abstract][Full Text] [Related]
4. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells.
Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H
Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538
[TBL] [Abstract][Full Text] [Related]
5. Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy.
Alavi Naini SM; Yanicostas C; Hassan-Abdi R; Blondeel S; Bennis M; Weiss RJ; Tor Y; Esko JD; Soussi-Yanicostas N
Transl Neurodegener; 2018; 7():6. PubMed ID: 29568517
[TBL] [Abstract][Full Text] [Related]
6. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
8. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
[TBL] [Abstract][Full Text] [Related]
9. DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling.
Bai X; Wu J; Zhang M; Xu Y; Duan L; Yao K; Zhang J; Bo J; Zhao Y; Xu G; Zu H
Front Aging Neurosci; 2021; 13():513605. PubMed ID: 33967735
[TBL] [Abstract][Full Text] [Related]
10. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
11. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
Ivashko-Pachima Y; Gozes I
Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone Attenuates Amyloid-β
Lyu D; Jia J
Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
[TBL] [Abstract][Full Text] [Related]
13. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.
Zhao D; Zhou Y; Huo Y; Meng J; Xiao X; Han L; Zhang X; Luo H; Can D; Sun H; Huang TY; Wang X; Zhang J; Liu FR; Xu H; Zhang YW
Cell Death Differ; 2021 Jan; 28(1):337-348. PubMed ID: 32908202
[TBL] [Abstract][Full Text] [Related]
14. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
[TBL] [Abstract][Full Text] [Related]
15. Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer's disease and tauopathy models.
Selvarasu K; Singh AK; Iyaswamy A; Gopalkrishnashetty Sreenivasmurthy S; Krishnamoorthi S; Bera AK; Huang JD; Durairajan SSK
Front Mol Biosci; 2022; 9():1050768. PubMed ID: 36387285
[TBL] [Abstract][Full Text] [Related]
16. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
17. A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
Zuo Y; Liu HT; Lin LB; Yue RZ; Liu HH; Wang HW; Wang L; Hou RL; Liu WZ; Li CZ; Wang JZ; Li P; Yin YL
Exp Neurol; 2024 Mar; 373():114657. PubMed ID: 38141802
[TBL] [Abstract][Full Text] [Related]
18. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
19. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
[TBL] [Abstract][Full Text] [Related]
20. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
